Ticker ARDS – Aridis Pharma – sales, description, marketcap – Tickerday.com

ARDS

Aridis Pharma

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 64.25M; Volume: 2.03K; AvgVol 3m: 11.04K; Beta: –;

Cost estimate:

P/E: –; EPS: -2.71; EPS growth quarter/prev quarter: 54.30%;

EPS growth this year: -21.30%; EPS growth past 5 years: ;

EPS ttm: -2.71;

P/S: 70.38; P/B: ; P/Cashflow: 5.96; P/FCF: ;

Sales: 1.00M; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -93.50%; ROE – return on equity: ; LT Debt/Equity: ; Total Debt/Equity: ;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 32.77%; Insider Transactions:0.00%;

Institutional Ownership: 1.20%; Institutional Transactions: 12.63%;

Data update: 07/10/2020.